Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 119094
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.119094
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.119094
Table 1 Normality test analysis for each variable
| W value | P value | |
| Age | 0.984 | 0.243 |
| BMI | 0.977 | 0.078 |
| Surgical time | 0.776 | 0.000a |
| Intraoperative blood loss | 0.648 | 0.000a |
| Duration of postoperative hospital stay | 0.715 | 0.000a |
| Postoperative anal evacuation time | 0.765 | 0.000a |
| Postoperative resumption of semi-liquid food time | 0.941 | 0.000a |
| Tumor height | 0.923 | 0.000a |
| Tumor maximum diameter | 0.947 | 0.000a |
| Anterior-posterior diameter of pelvic inlet | 0.980 | 0.122 |
| Transverse diameter of pelvic inlet | 0.991 | 0.729 |
| Anterior-posterior diameter of pelvic outlet | 0.977 | 0.070 |
| Interischial spine diameter | 0.964 | 0.008a |
| Interischial tuberosity diameter | 0.981 | 0.163 |
| Superior-inferior diameter of the pubic symphysis | 0.082 | 0.000a |
| Sacrococcygeal distance | 0.989 | 0.579 |
| sacrococcygeal-pubic angle | 0.131 | 0.000a |
| Anterior-posterior diameter of pelvic inlet/sacrococcygeal distance | 0.937 | 0.000a |
| Rectal mesenteric fat volume at the level of the superior border of the 3rd sacral vertebra | 0.948 | 0.001a |
| Rectal volume at the level of the superior border of the 3rd sacral vertebra | 0.877 | 0.000a |
| Rectal mesenteric fat volume at the level of the sciatic spine | 0.932 | 0.000a |
| Pelvic volume | 0.986 | 0.390 |
| Anorectal angle | 0.993 | 0.853 |
| Rectal mesenteric volume at the level of superior border of the 3rd sacral vertebra | 0.944 | 0.000a |
| Rectal mesenteric fat volume at the superior border of the 3rd sacral vertebra/pelvic volume | 0.981 | 0.195 |
Table 2 Clinical and pathological characteristics data of 103 patients in the laparoscopic low anterior resection for rectal cancer
| Range | mean ± SD/median (Q1, Q3) | Number of cases, n (%) | |
| Age (year) | 32-89 | 64.81 ± 11.832 | |
| Gender | |||
| Male | 71 (68.9) | ||
| Female | 32 (31.1) | ||
| BMI (kg/m2) | 15.94-33.980 | 22.63 ± 2.910 | |
| Underlying comorbidities | 48 (46.6) | ||
| Diabetes | 14 (13.6) | ||
| Hypertension | 39 (37.9) | ||
| Heart disease | 8 (7.8) | ||
| Pulmonary disease | 3 (2.9) | ||
| Stroke | 4 (3.9) | ||
| Other | 4 (3.9) | ||
| History of previous abdominal surgery | 16 (15.5) | ||
| Neoadjuvant therapy | 4 (3.9) | ||
| Hypoalbuminemia | 17 (16.5) | ||
| Anemia | 73 (70.9) | ||
| Blood transfusion | 2 (1.9) | ||
| Tumor height (cm) | 4-10 | 7 (6, 8) | |
| Tumor maximum diameter (cm) | 0.9-10 | 3.9 (3, 5) | |
| Intraoperative preventive ostomy | 36 (35.0) | ||
| pT/ypT staging | |||
| T0 | 1 (1.0) | ||
| Tis | 4 (3.9) | ||
| T1 | 12 (11.7) | ||
| T2 | 13 (12.6) | ||
| T3 | 70 (68.0) | ||
| T4a | 3 (2.9) | ||
| pN/ypN staging | |||
| N0 | 61 (59.2) | ||
| N1 | 26 (25.2) | ||
| N2 | 16 (15.5) | ||
| pTNM/ypTNM staging | |||
| 0 | 5 (4.9) | ||
| I | 20 (19.4) | ||
| II | 36 (35) | ||
| III | 42 (40.8) | ||
| Tumor differentiation grade | |||
| N/A | 2 (1.9) | ||
| Well-differentiated | 6 (5.8) | ||
| Moderately differentiated to well-differentiated | 11 (10.7) | ||
| Moderately differentiated | 70 (68) | ||
| Moderately differentiated to poorly differentiated | 11 (10.7) | ||
| Poorly differentiated | 3 (2.9) | ||
| Surgical time (minute) | 78-892 | 222.83 (173, 260) | |
| Intraoperative blood loss (mL) | 10-300 | 50 (20, 50) | |
| Postoperative complications (CD grade) | |||
| No complications | 77 (74.8) | ||
| I | 5 (4.9) | ||
| II | 16 (15.5) | ||
| III | 4 (3.9) | ||
| IV | 1 (1.0) | ||
| Duration of postoperative hospital stay (days) | 6-56 | 14 (12, 16) | |
| Postoperative anal evacuation time (days) | 1-7 | 2 (2, 3) | |
| Postoperative resumption of semi-liquid food time (days) | 3-17 | 7 (5, 9) |
Table 3 Within-group comparison of pelvic measurements and soft tissue measurements in 20 patients
| mean ± SD/median (Q1, Q3) | mean ± SD/median (Q1, Q3) | r value (correlation coefficient) | P value (correlation coefficient) | P value (mean or median difference) | |
| Anterior-posterior diameter of pelvic inlet (mm) | 114.07 ± 12.58 | 113.74 ± 12.72 | 0.998 | 0.000a | 0.936 |
| Transverse diameter of pelvic inlet (mm) | 120.91 ± 8.22 | 120.60 ± 8.16 | 0.998 | 0.000a | 0.905 |
| Anterior-posterior diameter of pelvic outlet (mm) | 87.98 ± 12.07 | 88.12 ± 11.68 | 0.998 | 0.000a | 0.971 |
| Interischial spine diameter (mm) | 91.56 (85.19, 106.16) | 91.02 (84.84, 106.15) | 0.992 | 0.000a | 0.892 |
| Interischial tuberosity diameter (mm) | 97.128 ± 14.21 | 96.53 ± 14.35 | 0.998 | 0.000a | 0.896 |
| Superior-inferior diameter of the pubic symphysis (mm) | 36.94 (33.34, 40.26) | 36.08 (32.99, 39.37) | 0.838 | 0.000a | 0.589 |
| Sacrococcygeal distance (mm) | 127.09 ± 12.19 | 126.82 ± 12.35 | 0.998 | 0.000a | 0.944 |
| sacrococcygeal-pubic angle (°) | 55.49 (46.10, 60.55) | 54.59 (46.58, 60.59) | 0.989 | 0.000a | 0.978 |
| Anterior-posterior diameter of pelvic inlet/sacrococcygeal distance | 0.90 (0.82, 0.98) | 0.90 (0.81, 0.98) | 0.994 | 0.000a | 0.957 |
| Rectal mesenteric fat volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 178.91 (137.08, 198.96) | 168.68 (135.51, 189.72) | 0.92 | 0.000a | 0.534 |
| Rectal mesenteric fat volume at the level of the sciatic spine (cm3) | 39.15 (33.12, 56.53) | 35.56 (30.62, 53.16) | 0.974 | 0.000a | 0.626 |
| Pelvic volume (cm3) | 849.37 ± 112.75 | 836.76 ± 109.53 | 0.978 | 0.000a | 0.722 |
| Anorectal angle (°) | 119.99 ± 14.88 | 119.67 ± 14.77 | 0.995 | 0.000a | 0.946 |
| Rectal mesenteric volume at the level of superior border of the 3rd sacral vertebra (cm3) | 247.14 (219.43, 301.38) | 241.78 (211.90, 297.89) | 0.892 | 0.000a | 0.516 |
| Rectal volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 78.49 (55.94, 119.31) | 68.76 (53.53, 123.11) | 0.991 | 0.000a | 0.589 |
| Rectal mesenteric fat volume at the superior border of the 3rd sacral vertebra/pelvic volume | 0.32 ± 0.08 | 0.31 ± 0.07 | 0.964 | 0.000a | 0.619 |
Table 4 Between-group comparison of pelvic measurements and soft tissue measurements in 20 patients
| mean ± SD/median (Q1, Q3) | mean ± SD/median (Q1, Q3) | r value (correlation coefficient) | P value (correlation coefficient) | P value (mean or median difference) | |
| Transverse diameter of pelvic inlet (mm) | 124.44 ± 6.87 | 123.84 ± 6.93 | 0.988 | 0.000a | 0.782 |
| Anterior-posterior diameter of pelvic outlet (mm) | 87.74 ± 8.45 | 87.61 ± 8.27 | 0.983 | 0.000a | 0.962 |
| Interischial spine diameter (mm) | 93.02 (86.26, 100.70) | 91.98 (86.63, 100.32) | 0.991 | 0.000a | 0.925 |
| Interischial tuberosity diameter (mm) | 96.90 ± 13.52 | 96.74 ± 13.33 | 0.997 | 0.000a | 0.969 |
| Superior-inferior diameter of the pubic symphysis (mm) | 38.24 (35.63, 41.85) | 37.68 (33.50, 42.26) | 0.896 | 0.000a | 0.589 |
| Sacrococcygeal distance (mm) | 122.33 ± 9.10 | 122.12 ± 9.05 | 0.992 | 0.000a | 0.940 |
| sacrococcygeal-pubic angle (°) | 50.56 (45.18, 55.68) | 51.35 (44.52, 54.76) | 0.956 | 0.000a | 0.620 |
| Anterior-posterior diameter of pelvic inlet/sacrococcygeal distance | 0.91 (0.83, 1.02) | 0.91 (0.84, 1.01) | 0.992 | 0.000a | 0.989 |
| Rectal mesenteric fat volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 170.50 (135.04, 213.31) | 169.18 (111.89, 235.48) | 0.814 | 0.000a | 0.968 |
| Rectal mesenteric fat volume at the level of the sciatic spine (cm3) | 31.10 (24.55, 48.92) | 30.85 (22.43, 46.44) | 0.856 | 0.000a | 0.883 |
| Pelvic volume (cm3) | 920.94 ± 110.70 | 946.28 ± 142.86 | 0.898 | 0.000a | 0.534 |
| Anorectal angle (°) | 104.79 ± 14.39 | 105.21 ± 14.37 | 0.996 | 0.000a | 0.926 |
| Rectal mesenteric volume at the level of superior border of the 3rd sacral vertebra (cm3) | 258.69 (212.54, 295.30) | 249.25 (185.80, 321.64) | 0.826 | 0.000a | 0.883 |
| Rectal volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 71.82 (58.29, 104.09) | 77.43 (59.98, 93.66) | 0.892 | 0.000a | 1.000 |
| Rectal mesenteric fat volume at the superior border of the 3rd sacral vertebra/pelvic volume | 0.28 ± 0.09 | 0.28 ± 0.12 | 0.909 | 0.000a | 0.955 |
Table 5 Gender comparison of pelvic and soft tissue parameters in 103 patients, mean ± SD/median (Q1, Q3)
| Total cases | Male (n = 71) | Female (n = 32) | P value | |
| Anterior-posterior diameter of pelvic inlet (mm) | 111.60 ± 12.86 | 107.21 ± 11.15 | 121.35 ± 11.01 | 0.000b |
| Transverse diameter of pelvic inlet (mm) | 122.90 ± 7.51 | 120.38 ± 6.36 | 128.50 ± 6.88 | 0.000b |
| Anterior-posterior diameter of pelvic outlet (mm) | 87.80 ± 8.86 | 85.837 ± 7.96 | 93.21 ± 8.47 | 0.000b |
| Interischial spine diameter (mm) | 92.54 (85.89, 101.40) | 88.70 (83, 93.66) | 106.35 (98.98, 108.94) | 0.000b |
| Interischial tuberosity diameter (mm) | 97.69 ± 12.95 | 92.88 (86.91, 97.61) | 111.28 (101.37, 118.30) | 0.000b |
| Superior-inferior diameter of the pubic symphysis (mm) | 39.67 (36.55, 43.26) | 39.92 (37.02, 44.22) | 38.35 (35.63, 42.49) | 0.180 |
| Sacrococcygeal distance (mm) | 123.40 ± 11.85 | 124.74 ± 11.14 | 120.44 ± 12.97 | 0.089 |
| sacrococcygeal-pubic angle (°) | 51.08 (45.10, 56.65) | 54.17 (48.06, 58.46) | 45 (40.76, 49.81) | 0.000b |
| Anterior-posterior diameter of pelvic inlet/sacrococcygeal distance | 0.89 (0.83, 0.97) | 0.85 (0.81, 0.91) | 1.01 (0.92, 1.05) | 0.000b |
| Rectal mesenteric fat volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 171.25 (136.59, 212.59) | 184.47 (146.11, 222.21) | 155.94 (119.33, 199.55) | 0.047a |
| Rectal volume at the level of the superior border of the 3rd sacral vertebra (cm3) | 66.87 (53.51, 95.88) | 66.19 (51.83, 91.02) | 69.68 (56.26, 100.46) | 0.613 |
| Rectal mesenteric fat volume at the level of the sciatic spine (cm3) | 33.59 (24.40, 46.15) | 40.42 (26.24, 49.66) | 28.16 (21.20, 35.76) | 0.001a |
| Pelvic volume (cm3) | 896.54 ± 113.97 | 876.50 ± 108.21 | 941.00 ± 115.49 | 0.007a |
| Anorectal angle (°) | 110.17 ± 16.36 | 110.11 ± 17.31 | 110.30 ± 14.29 | 0.958 |
| Rectal mesenteric volume at the level of superior border of the 3rd sacral vertebra (cm3) | 250.79 (205.78, 294.21) | 250.79 (215.41, 299.18) | 238.86 (194.19, 286.30) | 0.197 |
| Rectal mesenteric fat volume at the superior border of the 3rd sacral vertebra/pelvic volume | 0.2880 ± 0.079 | 0.3019 ± 0.078 | 0.2569 ± 0.073 | 0.007a |
Table 6 Comparison of clinicopathological data in both genders and short-term operative outcome in 103 patients with middle and lower rectal carcinoma
| Male (n = 71) | Female (n = 32) | P value | |
| Age (years) | 66 ± 11.98 | 62.16 ± 11.23 | 0.128 |
| BMI (kg/m2) | 22.56 ± 3.08 | 22.76 ± 2.54 | 0.748 |
| Underlying comorbidities | 39 (54.9) | 9 (28.1) | 0.012 |
| Diabetes | 9 (12.7) | 5 (15.6) | 0.926 |
| Hypertension | 31 (43.7) | 8 (25) | 0.071 |
| Heart disease | 8 (11.3) | 0 | 0.114 |
| Pulmonary disease | 3 (4.2) | 0 | 0.550 |
| Stroke | 2 (2.8) | 2 (6.3) | 0.777 |
| Other | 2 (2.8) | 2 (6.3) | 0.777 |
| History of previous abdominal surgery | 7 (9.9) | 9 (28.1) | 0.038a |
| Neoadjuvant therapy | 3 (4.2) | 1 (3.1) | 1.000 |
| Hypoalbuminemia | 14 (19.7) | 3 (9.4) | 0.191 |
| Anemia | 52 (73.2) | 21 (65.6) | 0.431 |
| Blood transfusion | 2 (2.8) | 0 | 1.000 |
| Tumor height (cm) | 7 (6, 8) | 8 (6.25, 10) | 0.063 |
| Tumor maximum diameter (cm) | 4 (3, 5) | 3.5 (3, 5) | 0.134 |
| Intraoperative preventive ostomy | 28 (39.4) | 8 (25) | 0.155 |
| pT/ypT staging | 0.420 | ||
| T0 | 0 | 1 | |
| Tis | 3 (4.2) | 1 (3.1) | |
| T1 | 8 (11.3) | 4 (12.5) | |
| T2 | 6 (8.5) | 7 (21.9) | |
| T3 | 52 (73.2) | 18 (56.3) | |
| T4a | 2 (2.8) | 1 (3.1) | |
| pN/ypN staging | 0.481 | ||
| N0 | 41 (57.7) | 20 (62.5) | |
| N1 | 17 (23.9) | 9 (28.1) | |
| N2 | 13 (18.3) | 3 (9.4) | |
| pTNM/ypTNM staging | 0.143 | ||
| 0 | 3 (4.2) | 2 (6.3) | |
| I | 9 (12.7) | 11 (34.4) | |
| II | 29 (40.8) | 7 (21.9) | |
| III | 30 (42.3) | 12 (37.5) | |
| Tumor differentiation grade | 0.094 | ||
| N/A | 1 (1.4) | 1 (3.1) | |
| Well-differentiated | 4 (5.6) | 2 (6.3) | |
| Moderately differentiated to well-differentiated | 7 (9.9) | 4 (12.5) | |
| Moderately differentiated | 45 (63.4) | 25 (78.1) | |
| Moderately differentiated to poorly differentiated | 11 (15.5) | 0 | |
| Poorly differentiated | 3 (4.2) | 0 | |
| Surgical time (minutes) | 222 (178, 265) | 195 (154.5, 239.25) | 0.216 |
| Intraoperative blood loss (mL) | 50 (30, 50) | 30 (20, 50) | 0.034a |
| Postoperative complications (CD grade) | 0.230 | ||
| No complications | 51 (71.8) | 26 (81.3) | |
| I | 3 (4.2) | 2 (6.3) | |
| II | 12 (16.9) | 4 (12.5) | |
| III | 4 (5.6) | 0 | |
| IV | 1 (1.4) | 0 | |
| Duration of postoperative hospital stay (day) | 14 (11, 16) | 13.5 (12, 16.75) | 0.983 |
| Postoperative anal evacuation time (day) | 2 (2, 2) | 2 (2, 3) | 0.156 |
| Postoperative resumption of semi-liquid food time (day) | 7 (4, 9) | 8 (5, 9) | 0.755 |
- Citation: Ke FY, Chen H, Liu JS, Li WC, Dhamija G, Viroja RD, Chen GP, Zhou XC. Clinical value of computed tomography-based three-dimensional reconstruction of the pelvis and mesorectum in middle to low rectal carcinoma. World J Gastrointest Surg 2026; 18(5): 119094
- URL: https://www.wjgnet.com/1948-9366/full/v18/i5/119094.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i5.119094